Rik Ossenkoppele
41 – 50 of 193
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The impact of tau-PET in a selected memory clinic cohort : rationale and design of the TAP-TAU study
- Contribution to journal › Article
-
Mark
Association of in vivo retention of [18f] flortaucipir pet with tau neuropathology in corresponding brain regions
- Contribution to journal › Article
-
Mark
Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease
- Contribution to journal › Article
-
Mark
Rationale and design of the BeyeOMARKER study : prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer’s disease pathology in the eye clinic
- Contribution to journal › Article
-
Mark
Biological mechanisms of resilience to tau pathology in Alzheimer’s disease
- Contribution to journal › Article
-
Mark
Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care
- Contribution to journal › Article
-
Mark
Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation model
- Contribution to journal › Article
-
Mark
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis
- Contribution to journal › Article
-
Mark
Disease staging of Alzheimer’s disease using a CSF-based biomarker model
- Contribution to journal › Article
-
Mark
Interactions between vascular burden and amyloid-β pathology on trajectories of tau accumulation
- Contribution to journal › Article
